News
Biocartis Announces Launch of the Brand-New Idylla™ POLE-POLD1 Mutation Assay Mechelen, Belgium, 02 April 2025 – Biocartis NV (“Biocartis”), an innovative molecular diagnostics company ...
Biocartis Announces Launch of the Brand-New Idylla™ POLE-POLD1 Mutation Assay ...
Mechelen, Belgium, 02 April 2025 – Biocartis NV (“Biocartis”), an innovative molecular diagnostics company, is pleased to announce the launch of the brand-new Idylla™ POLE-POLD1 Mutation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback